Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Cytomegalovirus Infections

3,4-dihydroxybenzohydroxamic acid has been researched along with Cytomegalovirus Infections in 1 studies

Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.

Research Excerpts

ExcerptRelevanceReference
"Ganciclovir (GCV) is a deoxyguanosine analog that is effective in inhibiting human cytomegalovirus (HCMV) replication."7.79Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir. ( Bhave, S; Elford, H; McVoy, MA, 2013)
"Ganciclovir (GCV) is a deoxyguanosine analog that is effective in inhibiting human cytomegalovirus (HCMV) replication."3.79Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir. ( Bhave, S; Elford, H; McVoy, MA, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhave, S1
Elford, H1
McVoy, MA1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Cytomegalovirus Infections

ArticleYear
Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
    Antiviral research, 2013, Volume: 100, Issue:1

    Topics: Antiviral Agents; Benzamidines; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergi

2013